Konstantinos Balaskas and Anitta Sharma discuss the HERMES trial, a cluster-randomised controlled trial investigating teleophthalmology innovations versus standard of care, including real-world implications of the AI involved and potential directions for future research and practice. Click here to read our latest issue Follow us today at... https://bsky.app/profile/lancetprimarycare.bsky.social https://www.linkedin.com/company/the-lancet https://instagram.com/thelancetgroup https://facebo...
All content for The Lancet Primary Care in conversation with is the property of The Lancet Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Konstantinos Balaskas and Anitta Sharma discuss the HERMES trial, a cluster-randomised controlled trial investigating teleophthalmology innovations versus standard of care, including real-world implications of the AI involved and potential directions for future research and practice. Click here to read our latest issue Follow us today at... https://bsky.app/profile/lancetprimarycare.bsky.social https://www.linkedin.com/company/the-lancet https://instagram.com/thelancetgroup https://facebo...
Konstantinos Balaskas and Anitta Sharma discuss the HERMES trial, a cluster-randomised controlled trial investigating teleophthalmology innovations versus standard of care, including real-world implications of the AI involved and potential directions for future research and practice. Click here to read our latest issue Follow us today at... https://bsky.app/profile/lancetprimarycare.bsky.social https://www.linkedin.com/company/the-lancet https://instagram.com/thelancetgroup https://facebo...
